AMARYL
Total Payments
$100,255
Transactions
25
Doctors
9
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $10,480 | 1 | 1 |
| 2020 | $32,713 | 5 | 1 |
| 2019 | $56,995 | 14 | 3 |
| 2018 | $66.15 | 5 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $43,609 | 2 | 43.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,252 | 3 | 33.2% |
| Travel and Lodging | $22,476 | 11 | 22.4% |
| Food and Beverage | $917.36 | 9 | 0.9% |
Top Doctors Receiving Payments for AMARYL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Endocrinology, Diabetes & Metabolism | Rancho Mirage, CA | $32,713 | 5 |
| , M.D | Endocrinology, Diabetes & Metabolism | San Diego, CA | $27,785 | 8 |
| , M.D | Specialist | Beverly Hills, CA | $25,527 | 5 |
| , MD | Internal Medicine | Iowa City, IA | $14,164 | 2 |
| Simon Farrow | — | Las Vegas, NV | $13.23 | 1 |
| , DO, JD | Neurology | Las Vegas, NV | $13.23 | 1 |
| , M.D | Neurology | Las Vegas, NV | $13.23 | 1 |
| , D.O | Neuromuscular Medicine | Las Vegas, NV | $13.23 | 1 |
| , D.O | Specialist | Las Vegas, NV | $13.23 | 1 |
Ad
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $100,189
- GENZYME CORPORATION $66.15
Product Information
- Type Drug
- Total Payments $100,255
- Total Doctors 9
- Transactions 25
About AMARYL
AMARYL is a drug associated with $100,255 in payments to 9 healthcare providers, recorded across 25 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2018 to 2021. In 2021, $10,480 was paid across 1 transactions to 1 doctors.
The most common payment nature for AMARYL is "Consulting Fee" ($43,609, 43.5% of total).